132 related articles for article (PubMed ID: 9675375)
1. Pharmacokinetics and pharmacodynamics in anesthetic drug development.
Shafer SL
Acta Anaesthesiol Belg; 1998; 49(2):65-78. PubMed ID: 9675375
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of fentanyl, alfentanil, and sufentanil in isoflurane-anesthetized cats.
Pypendop BH; Brosnan RJ; Majewski-Tiedeken CR; Stanley SD; Ilkiw JE
J Vet Pharmacol Ther; 2014 Feb; 37(1):13-7. PubMed ID: 23895731
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics, pharmacokinetics, and clinical uses of fentanyl, sufentanil, and alfentanil.
Willens JS; Myslinski NR
Heart Lung; 1993; 22(3):239-51. PubMed ID: 8387987
[TBL] [Abstract][Full Text] [Related]
4. The use of remifentanil in clinical anesthesia.
Philip BK
Acta Anaesthesiol Scand Suppl; 1996; 109():170-3. PubMed ID: 8901996
[No Abstract] [Full Text] [Related]
5. Basic principles of pharmacokinetics and pharmacodynamics for the anesthesiologist.
Camu F; Lauwers M; Vanlersberghe C
Acta Anaesthesiol Belg; 1998; 49(2):55-64. PubMed ID: 9675374
[No Abstract] [Full Text] [Related]
6. Propofol anesthesia and rational opioid selection: determination of optimal EC50-EC95 propofol-opioid concentrations that assure adequate anesthesia and a rapid return of consciousness.
Vuyk J; Mertens MJ; Olofsen E; Burm AG; Bovill JG
Anesthesiology; 1997 Dec; 87(6):1549-62. PubMed ID: 9416739
[No Abstract] [Full Text] [Related]
7. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
Scholz J; Steinfath M; Schulz M
Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, pharmacodynamics, and rational opioid selection.
Shafer SL; Varvel JR
Anesthesiology; 1991 Jan; 74(1):53-63. PubMed ID: 1824743
[TBL] [Abstract][Full Text] [Related]
9. Total intravenous anaesthesia (TIVA) in paediatrics: advantages and disadvantages.
Morton NS
Paediatr Anaesth; 1998; 8(3):189-94. PubMed ID: 9608961
[No Abstract] [Full Text] [Related]
10. Alfentanil causes less postoperative nausea and vomiting than equipotent doses of fentanyl or sufentanil in outpatients.
Langevin S; Lessard MR; Trépanier CA; Baribault JP
Anesthesiology; 1999 Dec; 91(6):1666-73. PubMed ID: 10598609
[TBL] [Abstract][Full Text] [Related]
11. [Sufentanil. An alternative to fentanyl/alfentanil?].
Ellmauer S
Anaesthesist; 1994 Mar; 43(3):143-58. PubMed ID: 8179164
[TBL] [Abstract][Full Text] [Related]
12. The in vitro effects of remifentanil, sufentanil, fentanyl, and alfentanil on isolated human right atria.
Hanouz JL; Yvon A; Guesne G; Eustratiades C; Babatasi G; Rouet R; Ducouret P; Khayat A; Bricard H; Gérard JL
Anesth Analg; 2001 Sep; 93(3):543-9. PubMed ID: 11524316
[TBL] [Abstract][Full Text] [Related]
13. The comparative effectiveness of fentanyl and its newer analogs during extracorporeal shock wave lithotripsy under monitored anesthesia care.
Gesztesi Z; Rego MM; White PF
Anesth Analg; 2000 Mar; 90(3):567-70. PubMed ID: 10702438
[No Abstract] [Full Text] [Related]
14. Accidental injection of remifentanil can cause a much more dangerous situation than the same dose of fentanyl.
Kunisawa T; Nagashima M; Suzuki A; Takahata O; Iwasaki H
J Anesth; 2010 Dec; 24(6):970-1. PubMed ID: 20721610
[No Abstract] [Full Text] [Related]
15. A review of the pharmacokinetics and pharmacodynamics of remifentanil.
Glass PSA; Gan TJ; Howell S
Anesth Analg; 1999 Oct; 89(4 Suppl):7. PubMed ID: 10511072
[No Abstract] [Full Text] [Related]
16. [Remifentanyl: pharmacokinetics, pharmacodynamics, use].
Mizikov VM; Lovtsevich NV; Rudenko MV; Vereshchagina II
Anesteziol Reanimatol; 1999; (6):19-22. PubMed ID: 11452762
[No Abstract] [Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil.
Lemmens HJ; Dyck JB; Shafer SL; Stanski DR
Clin Pharmacol Ther; 1994 Sep; 56(3):261-71. PubMed ID: 7924121
[TBL] [Abstract][Full Text] [Related]
18. Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil.
Ummenhofer WC; Arends RH; Shen DD; Bernards CM
Anesthesiology; 2000 Mar; 92(3):739-53. PubMed ID: 10719953
[TBL] [Abstract][Full Text] [Related]
19. A physiologically-based model to predict individual pharmacokinetics and pharmacodynamics of remifentanil.
Cascone S; Lamberti G; Piazza O; Abbiati RA; Manca D
Eur J Pharm Sci; 2018 Jan; 111():20-28. PubMed ID: 28939143
[TBL] [Abstract][Full Text] [Related]
20. The role of newer opioids in geriatric anesthesia.
Shafer SL
Acta Anaesthesiol Belg; 1998; 49(2):91-103. PubMed ID: 9675378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]